
About Alacrita
Alacrita is a Healthcare company based in Waltham (United States) founded in 2009. It offers consulting services for pharma and biotech development and business strategies. It operates on a B2B model. Its chief executive is Rob Johnson. Alacrita offers products and services including Product Development, Research & IP Evaluation, Clinical Development, and Business Development. Its focus areas include Pharmaceutical, Commercialization, Strategy and Biotech. Its legal entity is Alacrita Holdings Limited. Its competitors include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Alacrita is a consulting firm specializing in the pharmaceutical and biotechnology sectors, providing services such as product development, research evaluation, clinical strategies, and regulatory affairs. They support clients through expert networks for RD and commercialization, including opportunity mapping and deal-making. Based in London, UK, and Cambridge, MA, USA, they serve biotechs, pharmaceutical companies, investors, and tech transfer offices, leveraging multidisciplinary expertise to deliver tailored solutions.
- Headquarters Waltham, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website alacrita.com
- Social X
- Legal Name Alacrita Holdings Limited
Products & Services of Alacrita
Alacrita offers a comprehensive portfolio of products and services, including Product Development, Research & IP Evaluation, Clinical Development, and Business Development.
Support for pharma product development and optimization stages
Evaluation of research and intellectual property for biotech
Assistance in clinical trials and strategy execution
Services for asset scouting and deal-making in pharma
People of Alacrita
12 people are tracked at Alacrita (9 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Anthony Walker | Managing Partner | Leadership |
Rob Johnson | CEO | Leadership |
Christine Mccarthy | Partner | Leadership |
Stuart Hendry | Partner | Leadership |
William Slichenmyer | Partner | Leadership |
Mark Philip | Partner | Leadership |
Pierre Dodion | Partner | Leadership |
Gary Mansfield | Partner | Leadership |
Cort H. | Head Of Marketing & Outreach | Leadership |
Simon Turner | Strategic Advisor | Team |
Colin Wyatt | Associate | Team |
George Vella | Associate | Team |
Complete people profiles for Alacrita
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Alacrita
Alacrita has 9 listed competitors in our database, 4 of them funded. They include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| fishawack.com | 2001 | Brighton, United Kingdom | $23.59M | 45 | Fully integrated cross-border services are delivered to global pharmaceutical organizations. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| diaceutics.com | 2005 | Belfast, United Kingdom | – | 133 | Precision medicine integration is facilitated through analytics and services. | |
| sancilio.com | 2005 | Riviera Beach, United States | $27.25M | – | Innovative drug candidates are developed using proprietary Advanced Lipid Technologies. |
Detailed competitors of Alacrita
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Alacrita
Websites that share an audience with Alacrita (alacrita.com).
Websites whose visitors overlap most with Alacrita. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lambda-cro.com | 95% | 38.8K | #490,207 | View details | |
| trilogywriting.com | 91% | 6.3K | #3,520,858 | View details | |
| syneoshealth.com | 90% | 199.6K | #198,509 | View details | |
| lindushealth.com | 87% | 62.9K | #570,947 | View details | |
| askbio.com | 84% | 14.3K | #2,158,975 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Alacrita
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Alacrita (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alacrita
Complete news archive for Alacrita
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alacrita
Alacrita was founded in 2009.
Alacrita is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Rob Johnson is the current CEO of Alacrita.
Alacrita is a consulting firm specializing in the pharmaceutical and biotechnology sectors, providing services such as product development, research evaluation, clinical strategies, and regulatory affairs. They support clients through expert networks for RD and commercialization, including opportunity mapping and deal-making. Based in London, UK, and Cambridge, MA, USA, they serve biotechs, pharmaceutical companies, investors, and tech transfer offices, leveraging multidisciplinary expertise to deliver tailored solutions.
Alacrita's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Alacrita offers Product Development, Research & IP Evaluation, Clinical Development, and Business Development.
Alacrita operates through Alacrita Holdings Limited.
